June 4, 2004 Contact: Janet D'Alesandro (856) email@example.com FOR IMMEDIATE RELEASE NIH Launches National Kidney Disease Education Program American Nephrology Nurses’ Association Helping NIH to Raise Awareness PITMAN, NJ - The American Nephrology Nurses’ Association (ANNA) is working with the National Kidney Disease Education Program to raise awareness about the seriousness of kidney disease, the importance of testing those at high risk, and the availability of treatment to prevent or slow kidney failure. The National Kidney Disease Education Program’s (NKDEP) You Have The Power To Prevent Kidney Disease campaign seeks to bridge the gap between evidence and practice in detecting and treating chronic kidney disease (CKD). Over the past 10 years, significant advances have been made in CKD. Economical and effective testing and therapy now exist. Yet testing and therapy are being inadequately applied. As a result, the campaign is reaching out to primary care providers and other health professionals with important messages about kidney disease. Advances over the past 10 years include: Twenty-four hour urine collection is no longer necessary. Serum creatinine applied to a prediction equation to estimate GFR and a spot urine albumin to urine creatinine ratio are preferable to 24-hour urine collection. The NKDEP, the Kidney Disease Outcomes Quality Initiative (KDOQI) of the National Kidney Foundation, and the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) all recommend use of the MDRD equation to estimate GFR in adults. A GFR calculator is available at www.nkdep.nih.gov. Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) have proven safe, relatively simple and quite effective at slowing or halting the progression of CKD in diabetes and hypertension patients, and should be prescribed to protect kidney function in these patients. In addition, coordination among groups is enhancing patient care: Laboratories at the National Institutes of Health, the Veterans Administration and the Indian Health Service routinely report estimated GFR with creatinine values. LabCorp and Quest Diagnostics have announced that they also are beginning to report estimated GFR for their clients, and other laboratories are implementing similar measures. The NKDEP and the Renal Physicians Association have developed a Consult Form Template to facilitate communication between nephrologists and primary care providers and efficiently delineate areas of care. The template is available on the NKDEP and RPA Web sites. For more information about kidney disease, the campaign or how you can become involved, visit www.nkdep.nih.gov or call 1-866-4-KIDNEY. For more information about ANNA, visit www.annanurse.org. ANNA can also be reached at 888-600-2662, 856-256-2320; fax 856-589-7463; or via e-mail at firstname.lastname@example.org The National Kidney Disease Education Program is an initiative of the National Institutes of Health, U.S. Department of Health and Human Services. # # # ANNA is a professional association comprised of more than 11,500 nephrology nurses. Its mission is to advance nephrology nursing practice and positively influence outcomes for patients with kidney or other disease processes requiring replacement therapies through advocacy, scholarship, and excellence.